1 González N,PrietoI,Del Puerto-Nevado L,et al.2017 update on the relationship between diabetes and colorectal cancer:epidemiology,potential molecular mechanisms and therapeutic implications[J].Oncotarget,2017,8(11):18456-18485. 2 Yu X,Mao W,Zhai Y,et al.Anti-tumor activity of metformin:from metabolic and epigenetic perspectives[J].Oncotarget,2017,8(3):5619-5628. 3 Tseng CH.Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus[J].Oncotarget,2017,8(2):3042-3048. 4 Cai H,Zhang Y,Han TK,et al.Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells[J].Int J Cancer,2016,138(9):2281-2292. 5 Pulito C,Donzelli S,Muti P,et al.microRNAs and cancer metabolism reprogramming:the paradigm of metformin[J].Ann Trans Med,2014,2(6):58. 6 Gdowski A,Panchoo M,Treuren TV.Emerging therapeutics for targeting Akt in cancer[J].Front Biosci,2016,21:757-768. 7 Liu S,Chen S,Yuan W,et al.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/Akt and MAPK/ERK pathways[J].Oncotarget,2017,8(59):99901-99912. 8 Zhang J,Li G,Chen Y,et al.Metformin in hibits tumorigenesis and tumor growth of breast cancer cells by upregulating miR-200c but downregulating Akt2 expression[J].J Cancer,2017,8(10):1849-1864. 9 Thakur SS,LiH,Chan AMY,et al.The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer[J].PLoS One,2018,13(1):e0188983. 10 DeCensi A,Guerrieri-Gonzaga A,Gandini S,et al.Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer[J].Ann Oncol,2011,22(3):582-587. 11 Bonanni B,Puntoni M,Cazzaniga M,et al.Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial[J].J Clin Oncol,2012,30(21):2593-2600. 12 Chen S,Yao F,Xiao Q,et al.EZH2 inhibition sensitizes tamoxifen resistant breast cancer cells through cell cycle regulation[J].Mol Med Rep,2018,17(2):2642-2650. 13 Kim J,Lee J,Jang SY,et al.Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines[J].Oncol Rep,2016,35(5):2553-2560. 14 Engels CC,deGlas NA,Sajet A,et al.The influence of insulin-like growth factor-1-receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients:A Dutch TEAM substudy analysis[J].Mol Oncol,2016,10(4):509-516. 15 Hadad SM,Hardie DG,Appleyard V.Effects of metformin on breast cancer cell proliferation,the AMPK pathway and the cell cycle[J].Clin Transl Oncol,2014,16(8):746-752. 16 Scherbakov AM,Sorokin DV,Tatarskiy VV,et al.The phenomenon of acquired resistance to metformin in breast cancer cells:The interaction of growth pathways and estrogen receptor signaling[J].IUBMB Life,2016,68(4):281-292. 17 Parris AB,Zhao Q,Howard EW,et al.Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice[J].J Exp Clin Cancer Res,2017,36(1):28. 18 Sheng Q,Liu X,Fleming E,et al.An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells[J].Cancer Cell,2010,17(3):298-310. 19 Wilson TR,Lee DY,Berry L,et al.Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers[J].Cancer Cell,2011,20(2):158-172. 20 Kim J,Lee J,Kim C,et al.Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells[J].Tumour Biol,2016,37(5):5811-5819. 21 David CJ,Huang YH,Chen M,et al.TGF-β tumor suppression through a lethal EMT[J].Cell,2016,164(5):1015-1030. 22 Morales DR.Metformin in cancer treatment and prevention[J].Annu Rev Med,2015,66:17-29. 23 Wahdan-Alaswad R,Harrell JC,Fan Z,et al.Metformin attenuates transforming growth factor beta(TGF-β)mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer[J].Cell Cycle,2016,15(8):1046-1059. 24 Shi P,Liu W,Wang H,et al.Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation[J].Cell Discov,2017,3:17010. 25 Niraula S,Dowling RJ,Ennis M,et al.Metformin in early breast cancer:a prospective window of opportunity neoadjuvant study[J].Breast Cancer Res Treat,2012,135(3):821-830. 26 Zhang Y,Storr SJ,Johnson K,et al.Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy[J].Oncotarget,2014,5(24):12936-12949. 27 Ferro A,Goyal S,Kim S,et al.Evaluation of diabetic patients with breast cancer treated with metformin during adjuvant radiotherapy[J].Int J Cancer,2013,2013:659723. |